Company / Debt per Share
Krystal Biotech, Inc. Debt per Share History
FY2017-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$0.79
FY2017
5-year range
-
FY2017-FY2017
Trend
-
vs FY2016
Sector context
#66 of 82
Health Care
What the data says
Krystal Biotech, Inc.'s debt per share of $0.79 is lower than 80% of companies in the Health Care sector (FY2017).
Based on SEC 10-K filings.
0.79 in FY2017.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 20% in Health CareTop 20% of 82This company $0.79 Sector average $151.59
▼
-99.5% below sector average
Company context
Key Data Points
- Altman Z-Score 5.66 (safe zone, above 2.9 threshold)
- Strong profit margin: 30.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $0.79 | - |
| FY2016 | - | - |
As of FY2017 · SEC 10-K · Updated Feb 28, 2026